MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AxoGen Total Liabilities 2011-2026 | AXGN
Annual Total Liabilities AxoGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.8 M | 99.8 M | 101 M | 94.4 M | 95.5 M | 78.2 M | 22.5 M | 13.2 M | 33.7 M | 31.4 M | 29.4 M | 27.6 M | 27.5 M | 23.1 M | 6.42 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | 6.42 M | 51.8 M |
Quarterly Total Liabilities AxoGen
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93.2 M | 90.8 M | 99.8 M | 92.6 M | 93.2 M | 93.4 M | 101 M | 96.8 M | 94.5 M | 92 M | 94.4 M | 94.1 M | - | 94.2 M | 95.5 M | 94.7 M | 91.8 M | 77.7 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 6.42 M | 6.42 M | 6.42 M | 6.42 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | 6.42 M | 48.4 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.36 B | $ 184.69 | 2.23 % | $ 13.8 B |  USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.77 | 3.65 % | $ 1.73 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 292.23 | 1.41 % | $ 8.24 B | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.59 | 0.67 % | $ 36.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.37 | 1.35 % | $ 126 M |  France |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 39.9 | 2.18 % | $ 5.94 K | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 63.82 | 1.01 % | $ 94.5 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.34 | -1.71 % | $ 169 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | - | $ 17.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 10.38 | 3.7 % | $ 294 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 25.21 | 1.47 % | $ 213 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 6.04 | 2.03 % | $ 72.2 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
730 M | $ 94.94 | 2.11 % | $ 12.8 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.98 | -2.46 % | $ 1.2 M | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.44 | 3.74 % | $ 940 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.79 | 8.49 % | $ 33.1 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.86 | 5.37 % | $ 419 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.88 | 4.11 % | $ 390 M | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 56.83 | 3.48 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 39.73 | 3.3 % | $ 1.23 B | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 64.99 | 0.63 % | $ 3.55 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 88.63 | 1.03 % | $ 3.08 B | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.76 | 0.27 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 78.2 | 0.1 % | $ 45.7 B | USA |